Home Investing Quotes Stocks United States LBPWQ Options Stock Screener Earnings Calendar Sectors Search Ticker | LBPWQ U.S.: OTC 4D pharma PLC WtWatchlist Alert Closed Last Updated: Nov 22, 2024 10:48 a.m. EST Delayed quote $ 0.00 0.00 -99.00% Previous Close $0.00 ...
智通财经APP获悉,英国制药公司4D pharma plc宣布,公司已于3月18日召开股东大会,会议通过了公司与朗杰收购(LOAC.US)的合并协议,交易预计将于3月22日完成。 据悉,2020年10月22日,朗杰收购宣布,已和在伦敦AIM市场上市的4D pharma签署最终合并协议。合并完成后,朗杰将成为4D pharma的全资子公司。4D Pharma表示,交易完...
4D Pharma Plc Spons股票所在的生物技术行业中,整体涨幅为1.32%。其相关个股中,Artelo Biosciences Inc C/Wts 25/06/2024(To Pur Com)、Geovax Labs Inc C/Wts 29/09/2025(To Pur Com)、Immuron Limited C/Wts 08/06/2022 (To Pur Com)涨幅较大,Indaptus Therapeutics Inc、Siga Technologies Inc、Tonix...
智通财经APP获悉,3月18日,朗杰收购(LOAC.US)宣布其于2021年3月17日召开的特别股东大会结果:会议通过了公司与4d pharma plc、Dolphin Merge Sub Limited于2020年10月21日签订的合并协议以及其他相关交易。
公司名称4D PHARMA PLC C/WTS (TO PUR COM) CEOMr. Duncan Joseph Peyton 所属市场纳斯达克 董事高管 姓名 职务 年薪 Duncan Joseph Peyton Executive Director,Chief Executive Officer -- John Doyle Chief Financial Officer -- Dr. Alexander James Stevenson Executive Director,Chief Scientific Officer -- ...
另一个需要密切关注的流动性指标是速动比率。根据4D PHARMA PLC的最新财务结果,速动比率为3.17。 货币: 英镑 单季报 13.11 9.83 6.56 3.28 0 2017/Q4 10.04 -27.96% 2018/Q2 11.92 +50.43% 2018/Q4 5.07 -49.52% 2019/Q2 4.32 -63.74% 2019/Q4 ...
LinkedIn Facebook Email Print IPOEurope MORE ON THIS TOPIC Deals Roche Inks Potential $1.8B Deal With Flare to Target Transcription Factors in Cancer November 12, 2024 · 2 min read · Tristan Manalac Editorial Lilly vs. Novo: The ‘He Said, She Said’ Row About Catalent’s GLP-1 Work ...
4d Pharma Plc: “Clinical Update—RNS—London Stock Exchange”, Jul. 19, 2016. Anonymous: “4D pharma's Blautix for Irritable Bowel Syndrome shows positive impact—pharmaceutical daily news”, Dec. 13, 2016. Bernalier et al. Ruminococcus hydrogenotrophicus sp. nov., a new H2/CO2-utilizin...
4d Pharma Plc: “Clinical Update—RNS—London Stock Exchange”, Jul. 19, 2016. “Amedei, A. et al. Multiple sclerosis: the role of cytokines in pathogenesis and in therapies. Int J Mol Sci. Oct. 19, 2012;13(10):13438-60. doi: 10.3390/ijms131013438.”. Anonymous: “4D pharma's...
Johnson & Johnson Common Stock (JNJ) News Latest JNJ News StocksJohnson & Johnson's Quarterly Earnings Preview: What You Need to Know 3 days ago • Barchart Markets Validea Detailed Fundamental Analysis - JNJ 3 days ago • Validea Stocks Pharma Stock Roundup: PFE Ends Hemophilia ...